11 September 2024

SOLASTA Bio completes Series A investment round with $14m

We’ve just completed an oversubscribed $14M Series A funding round to accelerate our nature-inspired crop protection technology.
This milestone marks a significant step forward in our mission to revolutionise the global insecticides market with our unique bioinsecticides, which are as effective as synthetic chemicals but safe for key pollinators like bees.
With the support of our lead investor Forbion, co-leads FMC Ventures, and Corteva Catalyst, and existing investors Cavallo Ventures, Rubio Impact Ventures, Scottish Enterprise, UK Innovation & Science Seed Fund, SIS Ventures and University of Glasgow, we’re well-positioned to bring our products to market.
Thank you to everyone who has been part of our journey so far. We’re excited to continue pushing boundaries and driving sustainable innovation in crop protection.